Transforming the screening
and management of
diabetic eye disease.
GLOBAL DIABETES
500 million adults suffer
from diabetes worldwide
51% projected increase in global diabetes by 2045
1out of 3 diabetics
develop diabetic retinopathy
WHAT WE DO
Early Detection
Oivi’s product and service allows for early detection of diabetic retinopathy; reducing the number of people who suffer permanent loss of vision.
Rapid Diagnosis
Oivi drastically reduces time to
diagnosis, our intelligent camera and seamless service model shortens
time to treatment thereby reducing costs
for both patients and healthcare systems.
Point-of-need Care
Oivi enables diagnosis at the
point-of-need, reaching high-risk
diabetic patients right where ever
they may be located.
Expanding screening for eye diseases from
specialist clinics to primary care clinics
PRIMARY CARE CENTRES
DIABETES CLINICS
PHARMACIES
EYE HOSPITALS
OUR SUPPORT
THE TEAM
Anders Eikenes
CEO & CO-FOUNDER
Jukka Alasirnio
COO & CO-FOUNDER
